Pfizer PFE reported adjusted fourth-quarterly earnings of 55 cents per share on Tuesday, which missed the analyst consensus estimate of 57 cents by 3.51%. This is a 14.06% decrease over earnings of 64 cents per share from the same period last year.
The company reported quarterly sales of $12.7 billion, which beat the analyst consensus estimate of $12.61 billion by 0.71%. This is a 9.13% decrease over sales of $13.976 billion the same period last year.
Pfizer sees fiscal year 2020 adjusted EPS $2.82-$2.92 versus the $2.90 estimate and sales $48.5 billion-$50.5 billion versus the $49.52 billion estimate.
Pfizer shares were trading down 1.15% at $39.70 in Tuesday’s pre-market session. The stock has a 52-week high of $44.56 and a 52-week low of $33.97.
Related Links:
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.